Corticosteroids in rheumatoid arthritis
References (74)
- et al.
Long-term study of management of rheumatoid arthritis
Lancet
(1984) - et al.
Rheumatoid arthritis: Disease-modifying anti-rheumatic drugs
Clin Rheum Dis
(1983) - et al.
Hydrocortisone-mediated inhibition of monocyte antigen presentation: Dissociation of inhibitory effect and expression of DR antigens
Cell Immunol
(1984) - et al.
The effect of hydrocortisone on lymphocyte-mediated cytolysis
Cell Immunol
(1973) The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation
J Biol Chem
(1981)- et al.
Effect of antiinflammatory drugs and agents that elevate cyclic AMP on the release of toxic oxygen metabolites by phagocytes
Clin Immunol Immunopathol
(1978) - et al.
Adrenal glucocorticoids after twenty years
J Chron Dis
(1970) - et al.
A cross-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone
Lancet
(1987) - et al.
Local corticosteroid injection treatment in rheumatic disorders
- et al.
Prevention of steroid-induced osteoporosis with (3-amino-1 hydroxypropylidene)-1,1, bisphosphonate (APD)
Lancet
(1988)
Is atherosclerosis a complication of long term corticosteroid treatment?
Am J Med
Prophylaxis in patients receiving adrenal steroid therapy
J Chron Dis
Corticosteroid induced cataracts
Surv Ophthalmol
Drugcarrier potential of liposomes in cancer chemotherapy
Lancet
Liposomes in arthritis: A new approach
Lancet
Rheumatoid arthritis
The management of rheumatoid arthritis
Rheumatoid arthritis
The reversibility of certain rheumatic and non-rheumatic conditions by the use of cortisone or of the pituitary adrenocorticotropic hormone
Ann Intern Med
Some observations on the hormone of the adrenal cortex designated compound E
Rheumatism and arthritis
Ann Intern Med
The treatment of rheumatoid arthritis
A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis
Br Med J
Multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis
Ann Rheum Dis
A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis
Ann Rheum Dis
A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis
Ann Rheum Dis
Does drug therapy slow radiographic deterioration in rheumatoid arthritis?
N Engl J Med
Rheumatoid patients after five or more years of corticosteroid treatment: A comparative analysis of 183 cases
Ann Intern Med
Rheumatoid arthritis: The relevance of clinical knowledge to research activities
Abstr World Med
Low dose prednisone therapy in rheumatoid arthritis: A double blind study
J Rheumatol
Pulse methylprednisolone in rheumatoid arthritis
Ann Intern Med
Gold therapy in rheumatoid arthritis: Report of a multi-centre controlled trial
Ann Rheum Dis
Gold salts in the treatment of rheumatoid arthritis
Ann Intern Med
Effects of gold treatment on the progression of erosions in rheumatoid arthritis patients
Scand J Rheum
Mechanisms of glucocorticoid action on immune processes
Annu Rev Pharmacol Toxicol
Changes in connective tissue reaction induced by cortisone
Ann Intern Med
Corticosteroid-induced changes in phospholipid membranes as mediators of their action
Endocr Rev
Cited by (61)
Nrf2 activation improves experimental rheumatoid arthritis
2023, Free Radical Biology and MedicineInjectable PLGA/hydrocortisone formulation produced by continuous supercritical emulsion extraction
2013, International Journal of PharmaceuticsCitation Excerpt :Osteoarthritis usually involves one joint; while, rheumatoid arthritis normally attacks multiple joints as well as some organs. Conventional treatment of OA and RA includes intra-articular administration of glucocorticoids (Weiss, 1989); it has been recommended to reduce complications of oral administration and has been proved to produce symptomatic relief in joint inflammation. However, the systemic application is limited, due to a high incidence of serious side effects, especially related to long-term treatment; therefore, sustained release via carrier formulations can be significant to avoid the adverse effects and prolong the retaining time of the drug in the articular cavity over a period of some weeks.
In vivo quantitative photoacoustic monitoring of corticosteroid-induced vasoconstriction
2023, Journal of Biomedical Optics
- 1
From the Division of Rheumatology, Southern California Permanente Medical Group.